Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is
Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is